Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile
Michael "Mike" Albert, MD

@michaelalbertmd

Co-Founder, Chief Medical Officer @accomplishhlth | Obesity & Cardiometabolic Medicine | Clinical Incretinology | Healthcare Futurist

ID: 1010678065398087681

linkhttps://linktr.ee/MichaelAlbertMD calendar_today24-06-2018 00:16:43

20,20K Tweet

13,13K Followers

1,1K Following

Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo
Michael "Mike" Albert, MD
@michaelalbertmd

a year ago

My last thought on the #SELECT trial. Participants did not experience weight recurrence over 51 months. This provides strong evidence for the durability of incretin therapy for obesity. I’m actually unaware of any treatment that provides this level of durability.

My last thought on the #SELECT trial. Participants did not experience weight recurrence over 51 months. This provides strong evidence for the durability of incretin therapy for obesity. I’m actually unaware of any treatment that provides this level of durability.